GB9704370D0 - Levobupivacaine and its use - Google Patents

Levobupivacaine and its use

Info

Publication number
GB9704370D0
GB9704370D0 GBGB9704370.7A GB9704370A GB9704370D0 GB 9704370 D0 GB9704370 D0 GB 9704370D0 GB 9704370 A GB9704370 A GB 9704370A GB 9704370 D0 GB9704370 D0 GB 9704370D0
Authority
GB
United Kingdom
Prior art keywords
levobupivacaine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9704370.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chirotech Technology Ltd
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Priority to GBGB9704370.7A priority Critical patent/GB9704370D0/en
Publication of GB9704370D0 publication Critical patent/GB9704370D0/en
Priority to AU66305/98A priority patent/AU6630598A/en
Priority to PCT/GB1998/000658 priority patent/WO1998038997A1/en
Priority to ZA981782A priority patent/ZA981782B/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
GBGB9704370.7A 1997-03-03 1997-03-03 Levobupivacaine and its use Pending GB9704370D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9704370.7A GB9704370D0 (en) 1997-03-03 1997-03-03 Levobupivacaine and its use
AU66305/98A AU6630598A (en) 1997-03-03 1998-03-03 Use of levobupivacaine in combination with opiods or alfa2-agonists for providing anaesthesia or analgesia
PCT/GB1998/000658 WO1998038997A1 (en) 1997-03-03 1998-03-03 Use of levobupivacaine in combination with opiods or alfa2-agonists for providing anaesthesia or analgesia
ZA981782A ZA981782B (en) 1997-03-03 1998-03-03 The use of levobupivacaine in combination with other drugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9704370.7A GB9704370D0 (en) 1997-03-03 1997-03-03 Levobupivacaine and its use

Publications (1)

Publication Number Publication Date
GB9704370D0 true GB9704370D0 (en) 1997-04-23

Family

ID=10808616

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9704370.7A Pending GB9704370D0 (en) 1997-03-03 1997-03-03 Levobupivacaine and its use

Country Status (4)

Country Link
AU (1) AU6630598A (en)
GB (1) GB9704370D0 (en)
WO (1) WO1998038997A1 (en)
ZA (1) ZA981782B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
US20030087962A1 (en) 1998-10-20 2003-05-08 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US7973068B2 (en) 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
ES2239466T3 (en) * 1998-10-20 2005-09-16 Omeros Corporation IRRIGATION SOLUTION AND INHIBITION METHOD OF PAIN AND INFLAMMATION.
EP1563838A3 (en) * 1998-10-20 2009-11-04 Omeros Corporation Irrigation solution and method for inhibition of pain and inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU694453B2 (en) * 1993-10-13 1998-07-23 Darwin Discovery Limited Analgesic agent and its use
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use

Also Published As

Publication number Publication date
ZA981782B (en) 1999-03-03
AU6630598A (en) 1998-09-22
WO1998038997A1 (en) 1998-09-11

Similar Documents

Publication Publication Date Title
EP1032377A4 (en) Substituted 2-aminoacetamides and the use thereof
EP1037635A4 (en) Compounds and methods
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
EP1021185A4 (en) Didhydropyrimidines and uses thereof
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
GB9717598D0 (en) Novel composition and use
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
PL329351A1 (en) Piperidines and pyrolydines
GB9702354D0 (en) Compounds and their use
GB9704349D0 (en) Levobupivacaine and its use
PL331523A1 (en) Azolotrizines and azolopyrimidines
IL123535A0 (en) Benzoxazindione derivatives and their use
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
GB9704370D0 (en) Levobupivacaine and its use
EP0998578A4 (en) Sel-10 AND USES THEREOF
GB9718636D0 (en) Novel composition and use
PL341293A1 (en) Beta-lypothropin and application thereof
HUP9900068A3 (en) Fuse-switch and/or fuse-disconnector
GB9722023D0 (en) Levobupivacaine and its use
GB9724506D0 (en) Levobupivacaine and its use
GB9704369D0 (en) Levobupivacaine and its use
GB9722022D0 (en) Levobupivacaine and its use
GB9715462D0 (en) levobupivacaine and its use
GB9710080D0 (en) Levobupivacaine and its use
GB9715322D0 (en) Levobupivacaine and its use